About 1/3 of those who've experienced eye infections as a result of the use of Bausch & Lomb's ReNu eye contact solution are schedule to undergo corneal transplants. These new findings will be published in the Journal of the American Medical Association at the end of this month.
You can ping this entry by using http://www.saundersblog.com/cgi-bin/mt/mt-tb.cgi/331 .